A detailed history of Pdt Partners, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 16,310 shares of KOD stock, worth $150,867. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,310
Previous 16,310 -0.0%
Holding current value
$150,867
Previous $38,000 10.53%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$2.29 - $4.48 $37,349 - $73,068
16,310 New
16,310 $38,000
Q4 2022

Feb 14, 2023

SELL
$6.52 - $8.05 $156,773 - $193,562
-24,045 Reduced 29.56%
57,298 $410,000
Q3 2022

Nov 14, 2022

SELL
$7.57 - $12.5 $1.46 Million - $2.41 Million
-192,952 Reduced 70.34%
81,343 $630,000
Q2 2022

Aug 15, 2022

BUY
$5.04 - $9.48 $757,779 - $1.43 Million
150,353 Added 121.31%
274,295 $2.1 Million
Q1 2022

May 16, 2022

BUY
$7.09 - $89.45 $878,748 - $11.1 Million
123,942 New
123,942 $957,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $481M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.